Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0009 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |